Contact this trialFirst, we need to learn more about you.
Alkylating agents
Pembrolizumab + Cisplatin + IMRT for Head and Neck Cancer
Recruiting1 awardPhase 2
Pittsburgh, Pennsylvania
This trial is testing two different ways of using pembrolizumab to treat patients with head and neck cancer. The first is to give it along with the usual cisplatin and radiation therapy. The second is to give it after the patient has completed cisplatin and radiation therapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.